This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Validation of the NTX Wireless Patient Monitoring System (TATRC)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Dan France, Vanderbilt University
ClinicalTrials.gov Identifier:
NCT00644644
First received: March 19, 2008
Last updated: April 7, 2017
Last verified: April 2017
  Purpose
  • Reduction in time to detection of Clinically Significant events
  • Reduction of time to Intervention during Clinically Significant events
  • Reduction in the number of admissions to Intensive Care

Condition Intervention
Desaturation Bradycardia Tachycardia Hypertension Hypotension Other: Rapid Response Team (NTX wireless monitoring system)

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Validation of the NTX Wireless Patient Monitoring System in Combination With Novel Computer Interface to Generate Proactive Medical Responses to Patient Specific Events

Further study details as provided by Dan France, Vanderbilt University:

Primary Outcome Measures:
  • To determine if the NTX wireless monitoring system in combination with a novel computer interface will provide early detection of potentially life threatening changes in patient's vital signs [ Time Frame: an interim analysis will be performed after 400 patients have been placed on the study, again after 800 have been places on the study ]

Enrollment: 1303
Study Start Date: March 2008
Study Completion Date: January 2010
Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
monitored
Other: Rapid Response Team (NTX wireless monitoring system)
If the subject is experiencing a life threatening change in their vital signs, the Rapid Response Team will be initiated per VUMC protocol.
Other Name: - attending nurse action per VUMC protocol
2
control

Detailed Description:
1200 patients will have wireless monitors attached to their arm. They will be randomized to have their vital signs filtered through software that generates alerts, or software that does not generate alerts. Low and high limit alarms will be set according to published guidelines and adjusted at will by the response team. If appropriate the Vanderbilt University Medical Center Rapid Response team will be initiated per Institutional Policy
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Post-op orthopedic and GI patients who will be admitted for a minimum of 24 hours to the Round Wing area of Vanderbilt University Medical Center.
Criteria

Inclusion Criteria:

  • Ability to give written informed consent
  • Patients that are hospitalized for longer than 24 hours and are located on the 4th, 5th, or 6th floor of the Vanderbilt University Medical Center Round Wing
  • Patients must be ≥18 years of age

Exclusion Criteria:

  • ICU patients
  • Female subjects who are pregnant
  • Patients < 18 years of age
  • Patients that have a contradiction for continuous Blood Pressure monitoring
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00644644

Locations
United States, Tennessee
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37212
Sponsors and Collaborators
Vanderbilt University Medical Center
Investigators
Principal Investigator: Daniel J France, PhD, MPH Vanderbilt University Medical Center
  More Information

Additional Information:
Responsible Party: Dan France, Associate Professor, Vanderbilt University
ClinicalTrials.gov Identifier: NCT00644644     History of Changes
Other Study ID Numbers: 061241
Study First Received: March 19, 2008
Last Updated: April 7, 2017

Keywords provided by Dan France, Vanderbilt University:
NTX
Nihon Kohden
mobile monitoring

Additional relevant MeSH terms:
Hypotension
Tachycardia
Bradycardia
Vascular Diseases
Cardiovascular Diseases
Arrhythmias, Cardiac
Heart Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on September 20, 2017